ロード中...
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2018-05-01
|
| シリーズ: | Научно-практическая ревматология |
| 主題: | |
| オンライン･アクセス: | https://rsp.mediar-press.net/rsp/article/view/2524 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|